Medpace Holdings Inc Stock
Price
Target price
€370.80
€370.80
-1.580%
-5.9
-1.580%
€419.82
05.07.24 / Tradegate
WKN: A2APTV / Symbol: MEDP / Name: Medpace Holdings / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Medpace Holdings Inc Stock
A loss of -1.580% shows a downward development for Medpace Holdings Inc.
Medpace Holdings Inc is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
As a result the target price of 419 € shows a slightly positive potential of 13.0% compared to the current price of 370.8 € for Medpace Holdings Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Medpace Holdings Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Medpace Holdings Inc in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medpace Holdings Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | -1.580% | -5.951% | 3.181% | 69.932% | 32.740% | 145.395% | - |
| Galapagos N.V. | -0.260% | -0.769% | -8.215% | -39.511% | -37.257% | -60.449% | - |
| Novocure Ltd | -0.260% | -5.070% | -25.512% | -59.662% | 9.527% | -89.926% | - |
| Ironwood Pharmaceuticals | -2.610% | 0.877% | -7.258% | -39.153% | -43.627% | -46.262% | - |
Comments
Medpace Holdings, Inc. (NASDAQ: MEDP) is now covered by analysts at TD Cowen. They set a "buy" rating and a $452.00 price target on the stock.
Show more
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) is now covered by analysts at Mizuho. They set a "buy" rating and a $435.00 price target on the stock.
Show more
Ratings data for MEDP provided by MarketBeat
Medpace Holdings, Inc. (NASDAQ: MEDP) had its price target raised by analysts at Guggenheim from $453.00 to $464.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MEDP provided by MarketBeat